ORENCIA 250 mg powder for concentrate for solution for infusion, METHOTREXATE/PFIZER, ORENCIA 250 mg powder for concentrate for solution for infusion, ORENCIA 250 mg powder for concentrate for solution for infusion, DRL_AB
AB-01-004
Phase 3 small_molecule active
Quick answer
ORENCIA 250 mg powder for concentrate for solution for infusion, METHOTREXATE/PFIZER, ORENCIA 250 mg powder for concentrate for solution for infusion, ORENCIA 250 mg powder for concentrate for solution for infusion, DRL_AB for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Reddy Holding GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Reddy Holding GmbH
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active